Clinical Trials Browser

Phase 2 × Recruiting × Immune Checkpoint Inhibitors (ICI)-Related Dermatitis × Clear all

NCT06715982 2025-10-28

JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial

Phase 2 Recruiting

Immune Checkpoint Inhibitors (ICI)-Related Dermatitis